The Role of Citicoline in Neuroprotection and Neurorepair in Ischemic Stroke
Open Access
- 23 September 2013
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 3 (3), 1395-1414
- https://doi.org/10.3390/brainsci3031395
Abstract
Advances in acute stroke therapy resulting from thrombolytic treatment, endovascular procedures, and stroke units have improved significantly stroke survival and prognosis; however, for the large majority of patients lacking access to advanced therapies stroke mortality and residual morbidity remain high and many patients become incapacitated by motor and cognitive deficits, with loss of independence in activities of daily living. Therefore, over the past several years, research has been directed to limit the brain lesions produced by acute ischemia (neuroprotection) and to increase the recovery, plasticity and neuroregenerative processes that complement rehabilitation and enhance the possibility of recovery and return to normal functions (neurorepair). Citicoline has therapeutic effects at several stages of the ischemic cascade in acute ischemic stroke and has demonstrated efficiency in a multiplicity of animal models of acute stroke. Long-term treatment with citicoline is safe and effective, improving post-stroke cognitive decline and enhancing patients’ functional recovery. Prolonged citicoline administration at optimal doses has been demonstrated to be remarkably well tolerated and to enhance endogenous mechanisms of neurogenesis and neurorepair contributing to physical therapy and rehabilitation.This publication has 93 references indexed in Scilit:
- Intra-Arterial Thrombolysis vs. Standard Treatment or Intravenous Thrombolysis in Adults with Acute Ischemic Stroke: A Systematic Review and Meta-AnalysisInternational Journal of Stroke, 2013
- Citicoline in pre-clinical animal models of stroke: a meta-analysis shows the optimal neuroprotective profile and the missing steps for jumping into a stroke clinical trialJournal of Neurochemistry, 2012
- Citicoline induces angiogenesis improving survival of vascular/human brain microvessel endothelial cells through pathways involving ERK1/2 and insulin receptor substrate-1Vascular Cell, 2012
- Stroke-Related Translational ResearchArchives of Neurology, 2011
- Investigational Therapies for Ischemic Stroke: Neuroprotection and NeurorecoveryNeurotherapeutics, 2011
- Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trialThe Lancet Neurology, 2011
- Bihemispheric brain stimulation facilitates motor recovery in chronic stroke patientsNeurology, 2010
- Isolation of Locally Derived Stem/Progenitor Cells From the Peri-Infarct Area That Do Not Migrate From the Lateral Ventricle After Cortical StrokeStroke, 2010
- Current Status of Neuroprotection for Cerebral IschemiaStroke, 2009
- A role for VEGF as a negative regulator of pericyte function and vessel maturationNature, 2008